[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365960-105":59,"doc-detail-365960-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","prognostic-role-of-radiotherapy-in-low-grade-endometrial-stromal-sarcoma-a-seer-based-study","Prognostic Role of Radiotherapy in Low-Grade Endometrial Stromal Sarcoma: A SEER-Based Study","","Low-grade endometrial stromal sarcoma (LG-ESS) is rare, and radiotherapy strategy remains uncertain. A retrospective SEER-based analysis assessed whether external beam radiotherapy (EBRT) improves outcomes in 1,254 patients (2000–2021). Propensity score matching compared EBRT versus non-EBRT cohorts, followed by Cox and competing-risk models for overall survival (OS) and cancer-specific survival (CSS). EBRT showed no survival benefit in unmatched or matched groups. Prognosis correlated with older age, larger tumor size, advanced stage, and chemotherapy use, supporting individualized, risk-adapted management and further prospective validation.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-role-of-radiotherapy-in-low-grade-endometrial-stromal-sarcoma-a-seer-based-study/365960/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-role-of-radiotherapy-in-low-grade-endometrial-stromal-sarcoma-a-seer-based-study/365960.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main purpose regarding radiotherapy for LG-ESS?","Question",{"text":112,"@type":113},"To evaluate the prognostic significance of external beam radiotherapy (EBRT) for patients with low-grade endometrial stromal sarcoma using SEER data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients compared in the study?",{"text":117,"@type":113},"Researchers used a retrospective SEER cohort (2000–2021) and applied propensity score matching to balance EBRT and non-EBRT groups, then analyzed OS and CSS with Cox and competing-risk models.",{"name":119,"@type":110,"acceptedAnswer":120},"Did EBRT improve survival outcomes for LG-ESS patients?",{"text":121,"@type":113},"No. EBRT showed no survival benefit in either unmatched or matched cohorts for both OS and CSS.",{"name":123,"@type":110,"acceptedAnswer":124},"Which factors were associated with poorer prognosis?",{"text":125,"@type":113},"Older age, larger tumor size, advanced stage, and chemotherapy use were linked to poorer OS and CSS, while EBRT, lymphadenectomy, and BSO did not provide significant survival benefits.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},365960,1790474853,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","| Prognostic Role of Radiotherapy in Low-Grade Endometrial Stromal Sarcoma: A SEER-Based Study | Cancer Control Volume 32: 1-13 © The Author(s) 2025 Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/10732748251356935](DOI: 10.1177/10732748251356935)\u003Cbr>[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Huimin Jian, BM 1, Jinju Guo, BM2, Wenxin Zhao, BM 1, Wei Liu, BM 1, Yuan Xiang, BM3, and Xia Wang, PhD4,5,6 􀀁\u003Cbr>Abstract\u003Cbr>Introduction: Low-grade endometrial stromal sarcoma (LG-ESS) is a rare malignant mesenchymal neoplasm for which there is no consensus regarding the role of radiotherapy in treatment. This study aimed to evaluate the prognostic signiﬁcance of external beam radiotherapy (EBRT) using data from the Surveillance, Epidemiology, and End Results (SEER) database.\u003Cbr>Methods: This retrospective study evaluated the role of EBRT in 1254 patients with LG-ESS using SEER data (2000-2021). Propensity score matching (PSM) was applied to compare outcomes between EBRT and non-EBRT groups. Cox and competing risk models assessed overall survival (OS) and cancer-speciﬁc survival (CSS).\u003Cbr>Results: EBRT showed no survival beneﬁt in either unmatched or matched cohorts. Post-PSM, OS (HR = 1.21, 95% CI 0.61- 2.39) and CSS (HR = 1.75, 95% CI 0.69-4.43) remained unaffected by EBRT (P > 0.05). Lymphadenectomy and bilateral salpingectomy and oophorectomy (BSO) also demonstrated no signiﬁcant associations with survival outcomes. Key prognostic factors included older age, larger tumor size, advanced stage, and chemotherapy use, all linked to poorer OS and CSS. Conclusion: EBRT, lymphadenectomy, and BSO do not offer signiﬁcant survival beneﬁts for patients with LG-ESS. Prognosis was independently inﬂuenced by age, tumor size, stage, and chemotherapy use (associated with poorer outcomes). These ﬁndings support a more individualized, risk-adapted approach to LG-ESS management and highlight the need for prospective studies to deﬁne the optimal role of comprehensive treatment strategies.\u003Cbr>Plain Language Summary\u003Cbr>What is this study about?This study looked at whether radiation therapy, lymph node surgery, or ovary removal improves survival for patients with a rare type of uterine cancer called low-grade endometrial stromal sarcoma (LG-ESS). Because this cancer is uncommon, there’s limited evidence to guide treatment decisions. What did the researchers do?Using a U.S. national cancer database (2000–2021), the researchers analyzed data from 1,254 LG-ESS patients. They compared survival outcomes between those who received radiation therapy, lymph node surgery, or ovary removal and those who did not. Advanced statistical methods were used to balance differences between patient groups. What did they ﬁnd? Radiation therapy, lymph node surgery, and ovary removal did not improve survival for LG-ESS patients. Older age, larger tumor size, advanced cancer stage, |  |\n| 1 The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang, China\u003Cbr>2Department of Oncology, The Shangrao Medical Center, Second Afﬁliated Hospital of Nanchang University, Shangrao, China 3Department of Gynecology, Nanwai Community Health Service Center, Ganzhou, China\u003Cbr>4Department of Oncology, The Second Afﬁliated Hospital of Nanchang University, Nanchang, China 5Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, China 6Radiation-Induced Heart Damage Institute of Nanchang University, Nanchang, China\u003Cbr>Corresponding Author:\u003Cbr>Xia Wang, Department of Oncology, The Second Afﬁliated Hospital of Nanchang University, Nanchang University, No.1 Minde Street, Nanchang 330000, Jiangxi Province, People’s Republic of China.\u003Cbr>Email: [xiaoyaowangxia@163.com](xiaoyaowangxia@163.com) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nA","cbCaisA1ZdWYKj9n","https://ap.wps.com/l/cbCaisA1ZdWYKj9n","pdf",1111790,13,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion\n# Plain Language Summary\n## What is this study about?\n## What did the researchers do?\n## What did they find?\n## What does this mean for patients?","[{\"question\":\"What was the study’s main purpose regarding radiotherapy for LG-ESS?\",\"answer\":\"To evaluate the prognostic significance of external beam radiotherapy (EBRT) for patients with low-grade endometrial stromal sarcoma using SEER data.\"},{\"question\":\"How were patients compared in the study?\",\"answer\":\"Researchers used a retrospective SEER cohort (2000–2021) and applied propensity score matching to balance EBRT and non-EBRT groups, then analyzed OS and CSS with Cox and competing-risk models.\"},{\"question\":\"Did EBRT improve survival outcomes for LG-ESS patients?\",\"answer\":\"No. EBRT showed no survival benefit in either unmatched or matched cohorts for both OS and CSS.\"},{\"question\":\"Which factors were associated with poorer prognosis?\",\"answer\":\"Older age, larger tumor size, advanced stage, and chemotherapy use were linked to poorer OS and CSS, while EBRT, lymphadenectomy, and BSO did not provide significant survival benefits.\"}]","Prognostic Role of Radiotherapy in Low-Grade Endometrial Stromal Sarcoma: A SEER-Based Study | PDF",1790163133,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fd19935c566bf35370bd15b62545857.webp",983,1272,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b86f93ebf0b6e0ee4b37e7dcc69655b1.webp",982,1270,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86c47887a25a4a3a47845a9744e4badf.webp",981,1269,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04b0622042eec1cdf6be67f2aa8a9ec6.webp",980,1268]